Have you ever wondered what the future will look like? Well, you don’t have to …
Read More »Novo Nordisk limits distribution of low doses of Wegovy in U.S.
Novo Nordisk is holding back low doses of Wegovy, its recently approved obesity medication, in the U.S. to conserve supplies for patients already using the drug, the company said Thursday. The Danish drugmaker is supplying “limited quantities” of 0.25 mg, 0.5 mg and 1 mg dose strengths to wholesalers for distribution to …
Read More »





